Research and Markets has announced the addition of the "Diabetic
Neuropathic Pain - Global API Manufacturers, Marketed and Phase III
Drugs Landscape, 2017" drug pipelines to their offering.
Diabetic Neuropathic Pain - Global API Manufacturers, Marketed and Phase
III Drugs Landscape, 2017, provides comprehensive insights about the
marketed drugs, drug sales, Phase III pipeline drugs and their API
Manufacturers across the globe.
A key objective of the Diabetic Neuropathic Pain Report is to understand
the market and pipeline status of the drugs around the Diabetic
Neuropathic Pain to explore the generic development opportunities,
licensing opportunities and to gain competitive advantage on designing
pipeline strategies. The Report provides the historical and forecasted
sales of the drugs till 2018.
The Diabetic Neuropathic Pain Report gives insights into patents
providing the patent protection data and marketing exclusivity of all
the drugs across the Diabetic Neuropathic Pain.
While the leading brands, companies and chemicals are considered
thoroughly, the report also provides details on the Global API
Manufacturers across the globe covering Drug Master Filings of US,
Europe and API Manufacturers in Asia specifically China and India.
Key Topics Covered:
1. Indication Overview
2. Market Drugs Landscape
3. Global API Manufacturers Assessment
4. Phase III Drugs Landscape
5. Drugs Market Data and Forecasted Sales Figure-2018
6. Marketed Drugs for Diabetic Neuropathic Pain
7. Phase III Drugs for Diabetic Neuropathic Pain
8. Discontinued Drugs for Diabetic Neuropathic Pain
For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/dhslzl/diabetic
View source version on businesswire.com: http://www.businesswire.com/news/home/20170217005545/en/
Research and MarketsLaura Wood, Senior [email protected]
E.S.T Office Hours Call 1-917-300-0470For U.S./CAN Toll Free Call
1-800-526-8630For GMT Office Hours Call +353-1-416-8900U.S.
Fax: 646-607-1907Fax (outside U.S.): +353-1-481-1716Related
Nervous System Drugs , Analgesics,
and Metabolic Disorders Drugs